Los Angeles Capital Management
ARNA

Los Angeles Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Los Angeles Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,490
Closed -$441K – 1534
2020
Q1 		$441K Buy
+10,490
New +$481K ﹤0.01% 943
2019
Q2 		– Sell
-21,235
Closed -$952K – 1471
2019
Q1 		$952K Buy
+21,235
New +$974K 0.01% 870

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Los Angeles Capital Management's ARNA Position: Q2 2020 in Review

Los Angeles Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 10,490 shares — an estimated $441K sold.

Los Angeles Capital Management first reported a position in ARNA in Q1 2019 and held it in 2 quarters. The position peaked at $952K in Q1 2019. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

  • Los Angeles Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Los Angeles Capital Management sold 10,490 Arena Pharmaceuticals Inc shares in Q2 2020, an estimated $441K.
  • Los Angeles Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 2 quarters.
  • Los Angeles Capital Management's Arena Pharmaceuticals Inc position peaked at $952K in Q1 2019.
  • 247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Los Angeles Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.